1. Lung Cancer Prevalence: Lung cancer is the leading cause of cancer-related deaths in men worldwide. Smoking is the primary risk factor, with over 85% of cases linked to tobacco use. Symptoms: Persistent cough, coughing up blood, shortness of breath, chest pain, unexplained weight loss, recurrent respiratory infections. Risk Factors: Smoking, secondhand smoke exposure, occupational hazards (asbestos, radon), genetic predisposition. Diagnosis: Chest X-rays, CT scans, sputum cytology, bronchoscopy, and biopsy. Treatment: Surgery (lobectomy, pneumonectomy), chemotherapy, radiation therapy, targeted therapy, and immunotherapy. Prognosis: The five-year survival rate for lung cancer remains low, especially if diagnosed at a late stage. Early detection through screening in high-risk individuals can improve outcomes. 2. Prostate Cancer Prevalence: One of the most common cancers in men, especially in those over 50. Symptoms: Frequent urination (especially at night), weak urine stream, blood in urine or semen, erectile dysfunction, pelvic discomfort. Risk Factors: Age (risk increases with age), family history, high-fat diet, obesity, African-American ethnicity. Diagnosis: Digital rectal exam (DRE), prostate-specific antigen (PSA) test, MRI, biopsy. Treatment: Active surveillance (for low-risk cases), surgery (prostatectomy), radiation therapy, hormone therapy, chemotherapy. Prognosis: Highly treatable if detected early. Advanced stages may require aggressive treatment. 3. Colorectal Cancer Prevalence: A leading cause of cancer-related deaths in men, particularly those over 50. Symptoms: Changes in bowel habits (constipation or diarrhea), blood in stool, abdominal discomfort, unexplained weight loss, fatigue. Risk Factors: High-fat and low-fiber diet, obesity, sedentary lifestyle, smoking, heavy alcohol consumption, family history. Diagnosis: Colonoscopy, stool DNA tests, fecal occult blood test (FOBT), CT colonography. Treatment: Surgery (colectomy), chemotherapy, radiation therapy, targeted therapy. Prognosis: Early detection through routine screenings (colonoscopy) significantly improves survival rates. 4. Pancreatic Cancer Prevalence: One of the deadliest cancers due to late-stage diagnosis. Symptoms: Jaundice, unexplained weight loss, dark urine, light-colored stools, abdominal pain radiating to the back, loss of appetite. Risk Factors: Smoking, chronic pancreatitis, diabetes, obesity, genetic predisposition. Diagnosis: CT scan, MRI, endoscopic ultrasound (EUS), biopsy. Treatment: Surgery (Whipple procedure), chemotherapy, radiation therapy, targeted therapy. Prognosis: Poor prognosis due to aggressive nature and late detection. Less than 10% of patients survive five years after diagnosis. 5. Liver Cancer Prevalence: Often linked to chronic liver diseases like hepatitis B and C or cirrhosis. Symptoms: Jaundice, abdominal swelling, loss of appetite, nausea, easy bruising, unintentional weight loss. Risk Factors: Chronic hepatitis B or C infection, excessive alcohol consumption, fatty liver disease, exposure to aflatoxins. Diagnosis: Liver function tests, imaging (CT, MRI), biopsy. Treatment: Liver transplant (for eligible candidates), surgery (hepatectomy), radiofrequency ablation (RFA), chemotherapy. Prognosis: Early-stage liver cancer is treatable, but late-stage cases have limited treatment options.